Abel Robert Lorne 4

What Happened

• Robert Abel, EVP and Chief Scientific Officer, Platform at Schrodinger (listed as Abel Robert Lorne), sold 1,230 shares on Feb 9, 2026. The shares were sold at $13.51 per share for a total proceeds of $16,617. This was a sale (not a purchase) and appears to be a routine transaction to satisfy tax withholding.

Key Details

• Transaction date: 2026-02-09; Filing date: 2026-02-11.
• Transaction type: Sale (S) — 1,230 shares at $13.51 each; total $16,617.
• Holdings noted: filing indicates 15,137 unvested RSUs are included in reported holdings.
• Footnotes: Sale effected pursuant to a Rule 10b5-1 trading plan adopted June 13, 2023; it was a broker-assisted sale to cover withholding tax on vested RSUs and was not a discretionary trade by the reporting person.

Context

• Sales to cover tax withholding on RSU vesting are common and are generally considered routine rather than an indicator of management sentiment. The use of a 10b5-1 plan means the trade followed a pre-established plan and was not an ad-hoc decision by the insider.